GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report
Summary
GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
GlaxoSmithKline plc (GSK or 'the company') is a developer, manufacturer, and marketer of vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, Benlysta SCbelimumab, Benlysta, Augmentin, FluLaval, Bexsero, Menveo, Zovirax, Pronamel, Otrivin, Theraflu, Aquafresh, Abreva and Poligrip brand names. It merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. GSK has a business presence across the Americas, the Middle East, Africa, Australasia, and Europe. The company is headquartered in Brentford, Middlesex, the UK.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook